Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer



Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases free to download

Volume:20   Issue: 13
Pp: 1315-1316
Paulo Gustavo Kotze, Laurent Peyrin-Biroulet and Silvio Danese
DOI: 10.2174/138945012013190902150906



Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease

Volume:20   Issue: 13
Pp: 1317-1322
Amy L. Lightner*, Edward V. Loftus, Nicholas P. McKenna and Laura E. Raffals
DOI: 10.2174/1389450120666190325130142




Steroids and Postoperative Complications in IBD

Volume:20   Issue: 13
Pp: 1323-1326
Antonio López-Sanromán*
DOI: 10.2174/1389450120666190320122939



Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile

Volume:20   Issue: 13
Pp: 1327-1338
Marjorie Argollo, Paulo Gustavo Kotze, Laura Lamonaca, Daniela Gilardi, Federica Furfaro, Takayuki Yamamoto and Silvio Danese*
DOI: 10.2174/1389450120666190320110809




Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery

Volume:20   Issue: 13
Pp: 1339-1348
Takayuki Yamamoto*, Fabio Vieira Teixeira, Rogerio Saad-Hossne, Paulo Gustavo Kotze and Silvio Danese
DOI: 10.2174/1389450120666190404144048




Anti-TNF and Pouch Surgery for Ulcerative Colitis: The Ones who Blame for More Complications?

Volume:20   Issue: 13
Pp: 1349-1355
G. Bislenghi*, M. Ferrante and A. D’Hoore
DOI: 10.2174/1389450120666190328153200




Are Surgical Rates Decreasing in the Biological Era In IBD?

Volume:20   Issue: 13
Pp: 1356-1362
Francesca Di Candido*, Gionata Fiorino, Marco Spadaccini, Silvio Danese and Antonino Spinelli
DOI: 10.2174/1389450120666190426165325



Implication of Medical Treatment for Surgical Strategies in IBD

Volume:20   Issue: 13
Pp: 1363-1368
Krisztina B. Gecse* and Christianne J. Buskens
DOI: 10.2174/1389450120666190515095520



Pre-operative Exposure to Ustekinumab: A Risk Factor for Postoperative Complications in Crohn's Disease (CD)?

Volume:20   Issue: 13
Pp: 1369-1372
Hang Hock Shim*, Christopher Ma, Paulo Gustavo Kotze and Remo Panaccione
DOI: 10.2174/1389450120666190515094435



Medical-surgical Combined Approach in Perianal Fistulizing Crohn's Disease (CD): Doing it Together

Volume:20   Issue: 13
Pp: 1373-1383
Kapil Sahnan*, Samuel O Adegbola, Ana Fareleira, Ailsa Hart and Janindra Warusavitarne
DOI: 10.2174/1389450120666190520103454




Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?

Volume:20   Issue: 13
Pp: 1384-1398
Kalle Landerholm, Disa Kalman, Conny Wallon and Pär Myrelid*
DOI: 10.2174/1389450120666190617163919




Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis

Volume:20   Issue: 13
Pp: 1399-1408
Cigdem Benlice, Bo Shen and Scott R. Steele*
DOI: 10.2174/1389450120666190723130137